In Vitro and In Vivo Activities of Moxifloxacin and Clinafloxacin against Mycobacterium tuberculosis

On 10% oleic acid–albumin–dextrose–catalase-enriched 7H11 agar medium, the MIC at which 90% of the isolates are inhibited for 20 strains of Mycobacterium tuberculosis was 0.5 μg of sparfloxacin (SPFX) or moxifloxacin (MXFX) per ml and 1.0 μg of clinafloxacin (CNFX) per ml, indicating that the in vit...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Ji, Baohong, Lounis, Nacer, Maslo, Caroline, Truffot-Pernot, Chantal, Bonnafous, Pascale, Grosset, Jacques
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1998
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105862/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9687408/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.8.2066
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!